CO5150195A1 - Androgenos novedosos - Google Patents

Androgenos novedosos

Info

Publication number
CO5150195A1
CO5150195A1 CO00016933A CO00016933A CO5150195A1 CO 5150195 A1 CO5150195 A1 CO 5150195A1 CO 00016933 A CO00016933 A CO 00016933A CO 00016933 A CO00016933 A CO 00016933A CO 5150195 A1 CO5150195 A1 CO 5150195A1
Authority
CO
Colombia
Prior art keywords
androgens
new
ester
steroid
atom
Prior art date
Application number
CO00016933A
Other languages
English (en)
Spanish (es)
Inventor
Janjozef Loozen Hubert
Dirk Leysen
Van Der Louw Jaap
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of CO5150195A1 publication Critical patent/CO5150195A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO00016933A 1999-03-08 2000-03-08 Androgenos novedosos CO5150195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200665 1999-03-08

Publications (1)

Publication Number Publication Date
CO5150195A1 true CO5150195A1 (es) 2002-04-29

Family

ID=8239953

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00016933A CO5150195A1 (es) 1999-03-08 2000-03-08 Androgenos novedosos

Country Status (11)

Country Link
US (1) US6881728B1 (https=)
EP (1) EP1163259B1 (https=)
JP (1) JP4749550B2 (https=)
AR (1) AR022852A1 (https=)
AT (1) ATE228143T1 (https=)
AU (1) AU3162200A (https=)
CA (1) CA2359218A1 (https=)
CO (1) CO5150195A1 (https=)
DE (1) DE60000826T2 (https=)
PE (1) PE20001489A1 (https=)
WO (1) WO2000053619A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778017B2 (en) * 1999-12-02 2004-11-11 N.V. Organon 14,15-beta-methylene substituted androgens
DK1343806T3 (da) * 2000-12-11 2008-09-22 Organon Nv Methylensteroider som nye androgener
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
TWI221154B (en) * 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USB337823I5 (https=) * 1959-09-25 1976-03-23
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
US5264427A (en) * 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception

Also Published As

Publication number Publication date
JP4749550B2 (ja) 2011-08-17
ATE228143T1 (de) 2002-12-15
DE60000826T2 (de) 2003-04-10
EP1163259A1 (en) 2001-12-19
CA2359218A1 (en) 2000-09-14
AU3162200A (en) 2000-09-28
US6881728B1 (en) 2005-04-19
JP2002539135A (ja) 2002-11-19
DE60000826D1 (de) 2003-01-02
PE20001489A1 (es) 2000-12-29
AR022852A1 (es) 2002-09-04
WO2000053619A1 (en) 2000-09-14
EP1163259B1 (en) 2002-11-20

Similar Documents

Publication Publication Date Title
CO5271657A1 (es) Derivados de azaindol
DK1407017T3 (en) Human receptor for tumor nekrose faktor
CO5271716A1 (es) Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
NO20055253L (no) Behandling av autoimmun sykdom i en pasient med utilstrekkelig respons pa en TNF-alfa-inhibitor
DK0907652T3 (da) Immunosuppressive forbindelser og fremgangsmåder
PA8623601A1 (es) Protector para punta de aguja
CO5200785A1 (es) Uso terapeutico de quinazolina
CO5210886A1 (es) Aplicacion de compuestos de imidazolidin-2, 4-diona susti- tuida como antalgicos
ES2213707T3 (es) Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.
NO20011274D0 (no) Flashlagergruppe med indre oppfriskning
CO5450255A1 (es) Sistema de union de expansion para acomodar un movimiento grande en direcciones multiples
CO5271724A1 (es) Uso de agonistas de prostaglandinas para tratar la disfuncion erectil o la impotencia
CO5150195A1 (es) Androgenos novedosos
CO5271732A1 (es) Mecanismo estable de propulsar / repeler
CO5280205A1 (es) Forma cristalina de eplerenona .
DK1294732T3 (da) Ruthenium (II)-forbindelser til anvendelse i cancerterapi
AR031010A1 (es) Una composicion farmaceutica, util para inhibir el dano celular
AR028589A1 (es) PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE BIFENILO Y PROCEDIMIENTO PARA REDUCIR EL NIVEL DE DíMERO AQUIRAL EN LOS COMPUESTOS DE BIFENILO PREPARADOS
CO5221125A1 (es) Inhibidor de intercambiador de sodio hidrogeno de tipo 1
CO5190678A1 (es) Terapia combinada para el tratamiento de la migrana
CO5271714A1 (es) Cristales de inhibidor del intercambiador de sodio-hidrogeno
CO5241346A1 (es) Conjunto reflector con caras
CO5440228A1 (es) Tratamiento de la incontinencia urinaria
CO5070652A1 (es) Compuestos esteroides que tienen actividad supresora del apetito